Financial Statements — NYXH
Balance Sheet
(in millions EUR)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q3
2022 |
|---|
| Cash & Equivalents | 22.73 | 27.72 | 16.60 | 89.88 |
| Inventory | 5.33 | 5.10 | 1.15 | 0.59 |
| Total Current Assets | 55.11 | 89.68 | 91.33 | 119.34 |
| Total Non-current Assets | 61.36 | 58.56 | 51.09 | 44.73 |
| Total Assets | 116.47 | 148.23 | 142.41 | 164.07 |
| Total Current Liabilities | 20.95 | 16.38 | 15.24 | 20.01 |
| Total Non-current Liabilities | 22.13 | 11.71 | 11.60 | 10.99 |
| Total Liabilities | 43.07 | 28.09 | 26.84 | 31.00 |
| Retained Earnings | (260.21) | (185.54) | (142.52) | (105.06) |
| Total Stockholder Equity | 73.40 | 120.14 | 115.58 | 133.07 |
Income Statement
(in millions EUR) (except per-share rows)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q3
2022 |
|---|
| Gross Profit | 0.85 | 0.49 | 0.69 | 0.12 |
| Research & Development | 10.06 | 7.47 | 6.61 | 4.22 |
| Selling, General & Admin | 10.67 | 6.38 | 6.19 | 4.76 |
| Total Operating Expenses* | 20.70 | 13.80 | 12.57 | 8.90 |
| Operating Income | (19.85) | (13.31) | (11.88) | (8.78) |
| Pretax Income | (20.33) | (12.68) | (11.87) | (6.17) |
| Tax Provision | 0.28 | 0.44 | 0.93 | 0.07 |
| Net Income | (20.61) | (13.12) | (12.80) | (6.24) |
| Basic EPS | (0.55) | (0.43) | (0.45) | (0.24) |
| Diluted EPS | (0.55) | (0.43) | (0.45) | (0.24) |
* Derived from reported values
Cash Flow Statement
(in millions EUR)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q3
2022 |
|---|
| Operating Cash Flow | (35.25) | (23.59) | (22.48) | (18.39) |
| Investing Cash Flow | 26.79 | (15.56) | 3.89 | (31.64) |
| Financing Cash Flow | (1.20) | 44.98 | 17.80 | (0.76) |
